← Eichor
Study identifier: NCT05656794 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Consolidative Prostate Radiotherapy in Metastatic Prostate Cancer

Condition: Prostate Metastases  ·  Sponsor: University Health Network, Toronto

PhasePhase 2
Planned participants40
Who can joinMale, 18 Years to 100 Years
Healthy volunteersNo

About this study

This is a prospective, randomized phase II trial investigating if radiation treatment delivered every other day for 2 weeks has the same side effects as radiation treatment delivered once weekly for 6 weeks.

This description comes directly from the study's public registry record.

Talk to the study team

Peter Chung, MD  ·  416-946-4501  ·  peter.chung@rmp.uhn.ca

Always discuss trial participation with your own doctor first.

Locations (1)

University Health Network, Princess Margaret HospitalToronto, Ontario, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05656794